The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's Enhertu in combination with Roche ...
FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...
Testing for aldosterone levels may hold the key to treatment-resistant hypertension and many other cardiac conditions, but ...
After AstraZeneca and Daiichi Sankyo made waves in June with eye-opening results for Enhertu in a combination treatment for a ...
AstraZeneca ( AZN) and Daiichi Sankyo’s (DSNKY) Enhertu in combination with pertuzumab has been approved in the U.S. for the first-line treatment of adult patients with unresectable or metastatic HER2 ...
AstraZeneca PLC is rated a Buy due to strong growth, prudent R&D reinvestment, low leverage and resilience. Learn more about ...
Enhertu plus Perjeta is the first new first-line treatment for HER2-positive breast cancer in over a decade, approved by the ...
Patients with chronic spontaneous urticaria experienced relief in itch and hives by day 3 with povorcitinib, according to ...
The appeal of these diverse careers often lies in the different types of impact they enable. A PhD can teach more than ...
Fresh off a $153 million series E round, Arthrosi Therapeutics is skipping an IPO route and is instead being bought up for a ...
The Hechinger Report on MSN
The US wants more apprenticeships. The UK figured out how to make them coveted roles
England has embraced degree apprenticeship as a solution to a wide range of challenges, including high youth unemployment, spiraling student debt and rapid technological change. The programs have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback